Study #2020-0237
A Phase II double blind, placebo-controlled, randomized trial of artesunate vaginal inserts for the treatment of patients with cervical intraepithelial neoplasia (CIN2/3)
MD Anderson Study Status
Enrolling
Treatment Agent
Artesunate vaginal insert, Placebo vaginal insert
Description
This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
Study phase:
Phase II
Physician name:
Michaela Grinsfelder
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-844-513-2253
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.